Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Vir Biotechnology, Inc. (VIR)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vir Biotechnology, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Vir Biotechnology, Inc. since 2005.
The reporting company's ticker symbol is VIR. The reporting company's CIK number is 1706431.
The total value of stock buying since 2005 is $139,000,000.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-16||Platinum Falcon B 2018 Rsc Ltd||Buy||1,000,000||20.00||20,000,000|
|2019-10-16||Softbank Vision Fund (aiv M1) L.p. (10% Owner)||Buy||950,000||20.00||19,000,000|
|2019-10-16||Arch Venture Partners Ix, L.p. (10% Owner)||Buy||1,000,000||20.00||20,000,000|
|2019-10-16||Alaska Permanent Fund Corp||Buy||1,500,000||20.00||30,000,000|
|2019-10-16||Burow Kristina (Director)||Buy||1,000,000||20.00||20,000,000|
|2019-10-16||V-sciences Investments Pte Ltd (10% Owner)||Buy||500,000||20.00||10,000,000|
|2019-10-16||Nelsen Robert (Director)||Buy||1,000,000||20.00||20,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises of VIR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vir Biotechnology, Inc. (symbol VIR, CIK number 1706431) see the Securities and Exchange Commission (SEC) website.